Ellen B. Richstone
Ellen B. Richstone's purchase track record
How the stock did after each of Ellen B. Richstone's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/14/2025 | OESX | $49K | -10.8% | -25.3% | +5.5% |
| 6/14/2024 | OESX | $23K | -27.0% | -27.0% | +11.4% |
| 11/29/2023 | OESX | $28K | +7.7% | +6.6% | +15.7% |
| 6/9/2023 | OESX | $45K | -20.8% | -51.9% | +7.1% |
| 11/29/2022 | CGTX | $27K | -35.5% | -17.3% | +6.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Cognition Therapeutics Sets FDA Type C Meeting for Oct. 20. Cognition Therapeutics announced it will hold a Type C meeting with the FDA on October 20 regarding the planned trial of zervimesine. This regulatory step is a key milestone for the drug's development path. The company's stock currently trades within a wide 52-week range, reflecting the uncertainty typical of clinical-stage biotech firms.
Transaction History
| OESX | ▲ Buy | Grant | 2,532 | $0 | 8/11/2026 | View on chart |
| CGTX | ▲ Buy | Grant | 25,000 | $0 | 6/17/2026 | View on chart |
| OESX | ▲ Buy | Grant | 20,000 | $0 | 7/1/2025 | View on chart |
| CGTX | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 | View on chart |
| OESX | ▲ Buy | Open Market | 20,000 | $18K | 2/21/2025 | View on chart |
| OESX | ▲ Buy | Open Market | 874 | $772 | 2/20/2025 | View on chart |
| OESX | ▲ Buy | Open Market | 13,000 | $11K | 2/19/2025 | View on chart |
| OESX | ▲ Buy | Open Market | 13,000 | $11K | 2/18/2025 | View on chart |
| OESX | ▲ Buy | Open Market | 10,000 | $8K | 2/14/2025 | View on chart |
| OESX | ▲ Buy | Open Market | 20,000 | $23K | 6/14/2024 | View on chart |
| OESX | ▲ Buy | Grant | 27,523 | $0 | 6/11/2024 | View on chart |
| CGTX | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 | View on chart |
| OESX | ▲ Buy | Open Market | 30,000 | $28K | 11/29/2023 | View on chart |
| OESX | ▲ Buy | Grant | 19,355 | $0 | 8/15/2023 | View on chart |
| OESX | ▲ Buy | Open Market | 8,185 | $15K | 6/12/2023 | View on chart |
| CGTX | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 | View on chart |
| OESX | ▲ Buy | Open Market | 16,815 | $30K | 6/9/2023 | View on chart |
| CGTX | ▲ Buy | Open Market | 10,000 | $27K | 11/29/2022 | View on chart |
| OESX | ▲ Buy | Grant | 22,935 | $0 | 6/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Orion Energy Systems Highlights Role at FM Solutions Summit
Orion Energy Systems stepped into a leading role at the FM Solutions Summit and several other industry events this week. The appearances highlight the company’s growing presence in the renewable energy sector and may help it build new partnerships. The stock is currently trading above its 40‑touch support level of $9.39 and has an RSI of 56.1, indicating a neutral momentum.
Orion Energy Systems Highlights Role at FM Solutions Summit. Orion Energy Systems stepped into a leading role at the FM Solutions Summit and several other industry events this week. The appearances highlight the company’s growing presence in the renewable energy sector and may help it build new partnerships. The stock is currently trading above its 40‑touch support level of $9.39 and has an RSI of 56.1, indicating a neutral momentum.